Although the majority of marketed antidepressants are designed to boost low levels of the neurotransmitter serotonin in the brain-a well-known cause of depression-only a third of patients actually respond to the first drug they are...

Bacilligen Inc. . has three bacteria-based technology platforms that it believes confer safety, efficacy and manufacturing advantages when developing vaccines and therapeutics for infectious diseases and cancer, as well as allowing rapid manufacturing of therapeutic proteins...